Quantcast

Latest Biodefense Stories

2010-08-24 07:00:00

CHICAGO, Aug. 24 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional government funding for development of its novel, once-daily antibiotic, Restanza(TM) (cethromycin) based on a new, high-profile report from the Department of Health...

2010-08-06 07:40:00

CHANTILLY, Va., Aug. 6 /PRNewswire/ -- Rashid Chotani, M.D., M.P.H., has joined TASC, Inc. as director of Chemical-Biological Defense Programs. In this role, Chotani will lead chemical and biological programs that support the Defense Threat Reduction Agency (DTRA), U.S. Army and the Office of the Secretary of Defense, as well as civilian agencies such as Department of Homeland Security, National Institutes of Health and the Centers for Disease Control. (Logo:...

2010-07-08 07:00:00

ANNAPOLIS, Md., July 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE: Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70...

2010-06-25 06:00:00

PRINCETON, N.J., June 25 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article in the June 2010 edition of Vaccine, which describes protection from mucosal and systemic ricin intoxication by intradermal administration of RiVax(TM), the Company's vaccine against ricin toxin. The article was authored by the Company's collaborators at the University of Texas...

2010-06-09 05:00:00

ANNAPOLIS, Md., June 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the U.S. Government Accountability Office (GAO) has denied a competitor's protest, challenging a previously announced contract modification for up to $78.4 million for the Company's recombinant rPA anthrax vaccine, SparVax(TM). As a result of...

2010-06-07 08:08:00

ST. LOUIS, June 7 /PRNewswire-USNewswire/ -- CET, LLC participated in a bioterrorism recovery exercise at Joint Base Lewis-McChord, WA, in May 2010. The Interagency Biological Restoration Decontamination (IBRD) Device Demonstration was conducted to increase US preparedness to respond/recover from a bioterrorist attack. As part of the event, CET(TM) demonstrated the utility of Peridox® with EDS (Electrostatic Decontamination System) for destroying Anthrax spores on urban...

2010-06-01 10:39:00

ANNAPOLIS, Md., June 1 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Company will present at the Noble Financial Sixth Annual Equity Conference 'ONTRACK 2010' on Monday, June 7, 2010 at 4:00 p.m. ET in Room 3 - Piquet. The Company's presentation will be available via webcast under the Investor Relations...

2010-05-04 08:20:00

ANNAPOLIS, Md., May 4 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company's Interim CEO, Eric I. Richman, will be participating on a special biosecurity panel presentation promoting the critical interrelationship between government, academia and industry in the development of medical countermeasures vital to our nation's biosecurity. The panel...

2010-05-03 07:30:00

ANNAPOLIS, Md., May 3 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company's Board of Directors has appointed Eric I. Richman to the position of Interim Chief Executive Officer replacing David Wright, who has submitted his resignation. "PharmAthene's Board of Directors is pleased to appoint Eric Richman as the Company's new Interim Chief Executive...

2010-04-05 07:30:00

ANNAPOLIS, Md., April 5 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced the appointment of Thomas R. Fuerst, Ph.D., as the company's Senior Vice President, Chief Scientific Officer. In this newly created role, Dr. Fuerst will oversee PharmAthene's research and development programs and provide strategic scientific direction for the Company. Dr. Fuerst is a senior...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related